CME Group EBITDA 2010-2024 | CME

CME Group annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • CME Group EBITDA for the quarter ending September 30, 2024 was $1.108B, a 21.97% increase year-over-year.
  • CME Group EBITDA for the twelve months ending September 30, 2024 was $4.187B, a 16.39% increase year-over-year.
  • CME Group 2023 annual EBITDA was $3.788B, a 12.13% increase from 2022.
  • CME Group 2022 annual EBITDA was $3.379B, a 11.48% increase from 2021.
  • CME Group 2021 annual EBITDA was $3.031B, a 2.3% decline from 2020.
CME Group Annual EBITDA
(Millions of US $)
2023 $3,788
2022 $3,379
2021 $3,031
2020 $3,102
2019 $3,061
2018 $2,856
2017 $2,519
2016 $2,426
2015 $2,217
2014 $2,002
2013 $1,875
2012 $1,945
2011 $2,282
2010 $2,115
2009 $1,853
CME Group Quarterly EBITDA
(Millions of US $)
2024-09-30 $1,108
2024-06-30 $1,085
2024-03-31 $1,045
2023-12-31 $950
2023-09-30 $909
2023-06-30 $928
2023-03-31 $1,002
2022-12-31 $759
2022-09-30 $829
2022-06-30 $840
2022-03-31 $951
2021-12-31 $726
2021-09-30 $710
2021-06-30 $771
2021-03-31 $823
2020-12-31 $636
2020-09-30 $643
2020-06-30 $751
2020-03-31 $1,073
2019-12-31 $689
2019-09-30 $806
2019-06-30 $821
2019-03-31 $745
2018-12-31 $742
2018-09-30 $604
2018-06-30 $718
2018-03-31 $793
2017-12-31 $589
2017-09-30 $618
2017-06-30 $658
2017-03-31 $654
2016-12-31 $596
2016-09-30 $581
2016-06-30 $618
2016-03-31 $632
2015-12-31 $526
2015-09-30 $574
2015-06-30 $553
2015-03-31 $564
2014-12-31 $528
2014-09-30 $488
2014-06-30 $472
2014-03-31 $514
2013-12-31 $383
2013-09-30 $461
2013-06-30 $567
2013-03-31 $464
2012-12-31 $435
2012-09-30 $457
2012-06-30 $534
2012-03-31 $519
2011-12-31 $453
2011-09-30 $638
2011-06-30 $600
2011-03-31 $590
2010-12-31 $544
2010-09-30 $510
2010-06-30 $582
2010-03-31 $479
2009-12-31 $467
2009-09-30 $466
2009-06-30 $461
2009-03-31 $460
Sector Industry Market Cap Revenue
Finance Securities Exchanges $82.761B $5.579B
CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. CME Group offers a broad range of products covering major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. Trades are executed through CME Group's electronic trading platforms, open outcry and privately negotiated transactions. CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing and CME Clearing Europe, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. Apart from CME and CBOT, the company operates New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX), CME Clearing Europe Limited (CMECE) and CME Europe Limited (CME Europe). The company reports the results of its operations as one operating segment mainly comprised of CME, CBOT, NYMEX and COMEX.
Stock Name Country Market Cap PE Ratio
Intercontinental Exchange (ICE) United States $90.680B 26.86
Nasdaq (NDAQ) United States $46.073B 28.83
MarketAxess Holdings (MKTX) United States $10.098B 36.29
OTC Markets Group (OTCM) United States $0.640B 23.84